Literature DB >> 17470749

Acute transverse myelitis in childhood: center-based analysis of 47 cases.

F S Pidcock1, C Krishnan, T O Crawford, C F Salorio, M Trovato, D A Kerr.   

Abstract

OBJECTIVE: To relate clinical characteristics associated with acute transverse myelitis (ATM) in children with functional outcomes at follow-up.
METHODS: We identified 47 patients for whom ATM occurred under the age of 18 years. Chart analysis, clinical evaluation, and administration of functional measures were completed.
RESULTS: The age at onset clustered between ages 0 to 2 and 5 to 17. Febrile illness had occurred in 47% and vaccination in 28%. Major disability at the nadir of the clinical course was noted. Eighty-nine percent were unable to walk, required assisted ventilation, or both. At a median of 3.2 years after acute illness, 43% were unable to walk 30 ft and 21% required a walker or other support, 68% experienced urinary urgency, 50% required bladder catheterization, 54% were troubled by persistent dysesthesias, and 75% had numbness. Factors associated with a better functional outcome included older age at time of diagnosis, shorter time to diagnosis, lower sensory and anatomic levels of spinal injury, absence of T1 hypointensity on spinal MRI obtained during the acute period, lack of white blood cells in the CSF, and fewer affected spinal cord segments. Neither rapid progression to maximum impairment in less than 1 day nor any antecedent illness, immunization, or trauma was associated with a worse outcome.
CONCLUSION: Persisting disability was present in many children with acute transverse myelitis. Urinary problems and sensory symptoms were the most common issues. Age at onset below 3 years was associated with worse functional outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17470749     DOI: 10.1212/01.wnl.0000260609.11357.6f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  Acute transverse myelitis in Lyme neuroborreliosis.

Authors:  S Bigi; C Aebi; C Nauer; S Bigler; M Steinlin
Journal:  Infection       Date:  2010-05-27       Impact factor: 3.553

3.  Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.

Authors:  Leonard H Verhey; Helen M Branson; Monica Makhija; Manohar Shroff; Brenda Banwell
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

Review 4.  Acquired pathology of the pediatric spine and spinal cord.

Authors:  Susan Palasis; Laura L Hayes
Journal:  Pediatr Radiol       Date:  2015-09-07

5.  Case 2: Long-standing neuropathy with acute onset of weakness.

Authors:  Aleksandra Mineyko; Pierre Jacob
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

6.  Emergency Neurological Life Support: Acute Non-traumatic Weakness.

Authors:  Anna Finley Caulfield; Oliver Flower; Jose A Pineda; Shahana Uddin
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

7.  Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.

Authors:  Gregory Aaen; Michael Waltz; Wendy Vargas; Naila Makhani; Jayne Ness; Yolanda Harris; T Charles Casper; Leslie Benson; Meghan Candee; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Benjamin Greenberg; Timothy Lotze; Soe Mar; Jan-Mendelt Tillema; Mary Rensel; Moses Rodriguez; John Rose; Jennifer Rubin; Teri Schreiner; Amy Waldman; Bianca Weinstock-Guttman; Anita Belman; Emmanuelle Waubant; Lauren Krupp
Journal:  J Child Neurol       Date:  2018-12-17       Impact factor: 1.987

8.  Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings.

Authors:  Gulay Alper; Kalliopi A Petropoulou; Charles R Fitz; Yeonhee Kim
Journal:  Mult Scler       Date:  2010-09-21       Impact factor: 6.312

9.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

10.  Cyclophosphamide therapy in pediatric multiple sclerosis.

Authors:  N Makhani; M P Gorman; H M Branson; L Stazzone; B L Banwell; T Chitnis
Journal:  Neurology       Date:  2009-05-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.